Document is current
Any future updates will be listed below
-
Authors
Beerkens, Anne P. M.
Boreel, Daan F.
Nathan, James A.
Neuzil, Jiri
Cheng, Gang
Kalyanaraman, Balaraman
Hardy, Micael
Adema, Gosse J.
Heskamp, Sandra
Span, Paul N.
Bussink, Johan
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (13741, 13741, 13741, 13741, 13741)
- License Information
-
More Information
Article History
Received: 11 January 2024
Accepted: 25 April 2024
First Online: 3 May 2024
Declarations
:
: Not applicable.
: Not applicable.
: Jiri Neuzil is co-owner of the MitoTam intellectual property. Gang Cheng, Balaraman Kalyanaraman and Micael Hardy are inventors of WO2021081500A1, “Mitochondria-targeted atovaquone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug,” which is under consideration by the US Patent and Trademark Office. Anne PM Beerkens, Daan F Boreel, James A Nathan, Gosse J Adema, Sandra Heskamp, Paul N Span and Johan Bussink declare that they have no competing interests.
